ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ARRY Array Technologies Inc

13.06
0.00 (0.00%)
Pre Market
Last Updated: 09:01:24
Delayed by 15 minutes
Share Name Share Symbol Market Type
Array Technologies Inc NASDAQ:ARRY NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 13.06 12.00 13.28 8 09:01:24

Array Biopharma To Present At The Goldman Sachs 38th Annual Global Healthcare Conference

01/06/2017 3:00pm

PR Newswire (US)


Array Technologies (NASDAQ:ARRY)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Array Technologies Charts.

BOULDER, Colo., June 1, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Operating Officer, Andy Robbins, will present at the Goldman Sachs 38th Annual Global Healthcare Conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Event: 

Goldman Sachs 38th Annual Global Healthcare Conference

Presenter: 

Andy Robbins, Chief Operating Officer

Date: 

Tuesday, June 13, 2017

Time: 

10:00 a.m. Pacific Time

Webcast: 

https://cc.talkpoint.com/gold006/061317a_as/?entity=52_O16UKUL

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Seven Array-owned or partnered drugs are advancing in registration studies: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), larotrectinib (partnered with Loxo Oncology), tucatinib (partnered with Cascadian Therapeutics) and ipatasertib (partnered with Roche).

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-goldman-sachs-38th-annual-global-healthcare-conference-300466999.html

SOURCE Array BioPharma Inc.

Copyright 2017 PR Newswire

1 Year Array Technologies Chart

1 Year Array Technologies Chart

1 Month Array Technologies Chart

1 Month Array Technologies Chart

Your Recent History

Delayed Upgrade Clock